Dr. Thorpy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Sleep Wake Disorders Center
3411 Wayne Avenue Ground FL
Bronx, NY 10467Phone+1 718-920-4841Fax+1 718-798-4352
Education & Training
Montefiore Medical Center/Albert Einstein College of MedicineResidency, Neurology, 1980 - 1981
SUNY Upstate Medical UniversityResidency, Neurology, 1978 - 1980
University of Otago School of MedicineClass of 1973
Certifications & Licensure
NY State Medical License 1980 - 2027
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Expanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Daytime Sleepiness Associated With Narcolepsy With or Without Cataplexy
- A Study to Evaluate Safety, and Efficacy of SUVN-G3031 (Samelisant) in Patients With Narcolepsy With and Without Cataplexy Start of enrollment: 2019 Sep 21
Publications & Presentations
PubMed
- Social support and isolation in narcolepsy and idiopathic hypersomnia: An international survey.Julie Flygare, Lauren Oglesby, Sairam Parthasarathy, Michael J Thorpy, Emmanuel Mignot
Sleep Medicine. 2025-01-01 - Cataplexy response with extended-release once-nightly sodium oxybate: Post hoc responder analyses from the phase 3 REST-ON clinical trial.Michael J Thorpy, Clete A Kushida, Richard Bogan, Akinyemi O Ajayi, Bruce C Corser
Sleep Medicine. 2024-12-01 - 1 citationsImprovement in sleep latency with extended-release once-nightly sodium oxybate for the treatment of adults with narcolepsy: Analysis from the phase 3 REST-ON clinical ...Michael J Thorpy, Clete A Kushida, Richard Bogan, John Winkelman, Maurice M Ohayon
Sleep Medicine. 2024-12-01
Press Mentions
Investigational AXS-12 Reduces Cataplexy in Narcolepsy PatientsNovember 26th, 2024- New Narcolepsy Medication to Be Priced Competitively, Manufacturer SaysMay 7th, 2023
- FDA OKs Once-Nightly Sodium Oxybate for NarcolepsyMay 2nd, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
